Öztürk Ebru, Pehlivan Sacide, Ozcan Caglayan, Ugur Mete Gurol, Balat Ozcan
1 Bahceci Health Group, IVF Center, Istanbul, Turkey.
2 Department of Medical Biology and Genetics, Istanbul Medical School, Istanbul University, Istanbul, Turkey.
Genet Test Mol Biomarkers. 2019 Jul;23(7):501-505. doi: 10.1089/gtmb.2018.0245.
To evaluate the associations between idiopathic recurrent early pregnancy loss (REPL) and paraoxonase-1 () polymorphisms and the activities of its encoded enzymes. Ninety-eight women were enrolled in this study, including 21 currently pregnant multiparous women without a history of miscarriage; 18 multiparous women who were not pregnant during the study; 30 women with a history of idiopathic REPL who were pregnant; and 29 who were not. Paraoxonase (PONase) and arylesterase (AREase) activities, two activities of the PON1 enzyme, were measured through commercially available kits (Relassay, Gaziantep, Turkey). genotypes were determined by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) analysis. Data were analyzed using SPSS for Windows version 19.0 (SPSS). There was no association between idiopathic REPL and polymorphisms or PONase activity. The AREase activity of the enzyme trended higher in the healthy pregnant group than in the healthy nonpregnant group ( = 0.067), and was higher in the pregnant group with a history of idiopathic REPL than in the nonpregnant group with a history of idiopathic REPL ( = 0.041). Despite there being no detected association between PON1 activities or genotype and idiopathic REPL, we showed that AREase activity increased during early gestation. New studies, including longitudinal changes in serum AREase activity throughout normal pregnancy, should be carried out to further evaluate the association between PON encoded enzymatic activities and early gestational pathophysiology.
评估特发性复发性早期妊娠丢失(REPL)与对氧磷酶-1()基因多态性及其编码酶活性之间的关联。本研究纳入了98名女性,包括21名目前怀孕的经产妇且无流产史;18名在研究期间未怀孕的经产妇;30名有特发性REPL病史且怀孕的女性;以及29名未怀孕的女性。通过市售试剂盒(Relassay,土耳其加济安泰普)测量对氧磷酶(PONase)和芳基酯酶(AREase)活性,这是PON1酶的两种活性。通过聚合酶链反应和限制性片段长度多态性(PCR-RFLP)分析确定基因型。使用SPSS for Windows 19.0版(SPSS)对数据进行分析。特发性REPL与基因多态性或PONase活性之间无关联。健康怀孕组中该酶的AREase活性比健康未怀孕组有升高趋势(=0.067),有特发性REPL病史的怀孕组中的AREase活性高于有特发性REPL病史的未怀孕组(=0.041)。尽管未检测到PON1活性或基因型与特发性REPL之间存在关联,但我们发现AREase活性在妊娠早期增加。应开展新的研究,包括整个正常妊娠期间血清AREase活性的纵向变化,以进一步评估PON编码酶活性与早期妊娠病理生理学之间的关联。